Manassantin A
Code | Size | Price |
---|
TAR-TN4489-10mg | 10mg | £1,099.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-TN4489-1mL | 1 mL * 10 mM (in DMSO) | £1,115.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
Manassantin A is a high potent HIF-1 inhibitor, it protects the gastric mucosa from ethanol-induced acute gastric injury, and suggest that these protective effects might be associated with COX/PGE2 stimulation, inhibition of iNOS production and NF-κB activation, and improvements in the antioxidant and anti-inflammatory status.Manassantin A represents a potential therapeutic approach for the treatment of airway allergic-inflammatory diseases. Manassantin A inhibits cAMP-induced melanin production by down-regulating the gene expressions of MITF and tyrosinase in melanocytes.
CAS:
88497-87-4
Molecular Weight:
732.867
Pathway:
Chromatin/Epigenetic|MAPK|GPCR/G Protein|NF-κb|Stem Cells|Immunology/Inflammation|Apoptosis|Angiogenesis|JAK/STAT signaling|Neuroscience
Purity:
0.98
SMILES:
[H][C@@]1(O[C@@]([H])([C@H](C)[C@H]1C)c1ccc(O[C@H](C)[C@H](O)c2ccc(OC)c(OC)c2)c(OC)c1)c1ccc(O[C@H](C)[C@H](O)c2ccc(OC)c(OC)c2)c(OC)c1
Target:
cAMP|COX|ERK|MAPK|NF-κB|HIF|TNF|Prostaglandin Receptor|JNK|STAT